Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Cerebrovascular Disorders

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 75 articles:
HTML format



Single Articles


    June 2026
  1. LU Y, Wang Y
    Minocycline for acute ischaemic stroke: limitations of the EMPHASIS trial - Authors' reply.
    Lancet. 2026;407:2290.
    PubMed    


  2. GHOZY S, Abbas AS, Kadirvel R, Rabinstein AA, et al
    Minocycline for acute ischaemic stroke: limitations of the EMPHASIS trial.
    Lancet. 2026;407:2289-2290.
    PubMed    


    May 2026
  3. WANG A, Xia X, Tang Y, Zhang F, et al
    Ticagrelor with aspirin dual antiplatelet therapy combined with intravenous thrombolysis in patients with ischaemic stroke in China (TAPIS): a multicentre, double-blind, randomised controlled trial.
    Lancet. 2026;407:1919-1928.
    PubMed     Abstract available


  4. ZWAM WV, Fischer U
    Is ATLAS lifting the burden of stroke in people with large-vessel occlusion and low ASPECTS scores?
    Lancet. 2026 May 7:S0140-6736(26)00873-1. doi: 10.1016/S0140-6736(26)00873.
    PubMed    


  5. SARRAJ A, Thomalla G, Yoshimura S, Huo X, et al
    Endovascular thrombectomy for patients with large-core ischaemic stroke presenting up to 24 h after onset (ATLAS): a systematic review and individual patient data meta-analysis with central imaging adjudication.
    Lancet. 2026 May 7:S0140-6736(26)00876-7. doi: 10.1016/S0140-6736(26)00876.
    PubMed     Abstract available


    March 2026
  6. DELEWI R, Aarts HM, Broeze GM, Hemelrijk KI, et al
    Deferral of percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation (PRO-TAVI): an investigator-initiated, multicentre, open-label, non-inferiority, randomised controlled trial.
    Lancet. 2026 Mar 29:S0140-6736(26)00308-9. doi: 10.1016/S0140-6736(26)00308.
    PubMed     Abstract available


  7. KANG J, Park S, Yang HM, Shin ES, et al
    Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention: 10-year follow-up of the HOST-EXAM trial.
    Lancet. 2026 Mar 29:S0140-6736(26)00422-8. doi: 10.1016/S0140-6736(26)00422.
    PubMed     Abstract available


  8. COLOMBATTI R, Jastaniah W, Makani J, Andemariam B, et al
    Sickle cell disease.
    Lancet. 2026;407:1095-1111.
    PubMed     Abstract available


  9. LANE DA, Andrade JG, Arbelo E, Boriani G, et al
    Atrial fibrillation.
    Lancet. 2026;407:1000-1013.
    PubMed     Abstract available


    February 2026
  10. WANG N, Salam A, Rodgers A
    Simplifying and improving heart attack and stroke prevention - Authors' reply.
    Lancet. 2026;407:572.
    PubMed    


  11. WALD NJ, Hingorani AD, Morris JK
    Simplifying and improving heart attack and stroke prevention.
    Lancet. 2026;407:571-572.
    PubMed    


  12. TSIVGOULIS G, Palaiodimou L, Turc G
    Intravenous tenecteplase for acute ischaemic stroke within 24 h due to basilar artery occlusion.
    Lancet. 2026 Feb 5:S0140-6736(26)00139-X. doi: 10.1016/S0140-6736(26)00139.
    PubMed    


  13. XIONG Y, Alemseged F, Cao Z, Schwamm LH, et al
    Tenecteplase versus standard medical treatment for basilar artery occlusion within 24 h (TRACE-5): a multicentre, prospective, randomised, open-label, blinded-endpoint, superiority, phase 3 trial.
    Lancet. 2026 Feb 5:S0140-6736(25)02633-9. doi: 10.1016/S0140-6736(25)02633.
    PubMed     Abstract available


  14. ANDERSON CS, Chen C, Salman RA
    Testing early haemostatic therapy for acute intracerebral haemorrhage.
    Lancet. 2026 Feb 4:S0140-6736(26)00146-7. doi: 10.1016/S0140-6736(26)00146.
    PubMed    


  15. BRODERICK JP, Naidech AM, Elm JJ, Toyoda K, et al
    Recombinant factor VIIa versus placebo for spontaneous intracerebral haemorrhage within 2 h of symptom onset (FASTEST): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
    Lancet. 2026 Feb 4:S0140-6736(26)00097-8. doi: 10.1016/S0140-6736(26)00097.
    PubMed     Abstract available


    January 2026
  16. LU Y, Guan L, Wu J, Yang Q, et al
    Efficacy and safety of minocycline in patients with acute ischaemic stroke (EMPHASIS): a multicentre, double-blind, randomised controlled trial.
    Lancet. 2026 Jan 30:S0140-6736(25)01862-8. doi: 10.1016/S0140-6736(25)01862.
    PubMed     Abstract available


    December 2025
  17. ANDERSON CS, Sui Y, Urrutia VC
    The importance of patient selection in stroke monitoring research - Authors' reply.
    Lancet. 2025;406:2756.
    PubMed    


  18. HAYASHI S, Yasuda T, Shiraishi A
    The importance of patient selection in stroke monitoring research.
    Lancet. 2025;406:2755-2756.
    PubMed    


    October 2025
  19. KIRBY T
    Xunming Ji: preventing and treating stroke in China.
    Lancet. 2025 Oct 27:S0140-6736(25)02176-2. doi: 10.1016/S0140-6736(25)02176.
    PubMed    


  20. CACOUB P, Vieira M, Langford CA, Tazi Mezalek Z, et al
    Large-vessel vasculitis.
    Lancet. 2025;406:2017-2032.
    PubMed     Abstract available


    August 2025
  21. CHENG SP, Chen PH, Jhou HJ
    Timing of cardiac surgery and anticoagulants after acute ischaemic stroke.
    Lancet. 2025;406:601.
    PubMed    


  22. WERRING DJ, Dehbi HM, Best JG, Nash PS, et al
    Timing of cardiac surgery and anticoagulants after acute ischaemic stroke - Authors' reply.
    Lancet. 2025;406:601-602.
    PubMed    


  23. POCAR M, Barbero C, Cerrato P, De Rosa FG, et al
    Timing of cardiac surgery and anticoagulants after acute ischaemic stroke.
    Lancet. 2025;406:600-601.
    PubMed    


    June 2025
  24. ZIAI WC, Tsivgoulis G
    Timing of anticoagulation after ischaemic stroke and atrial fibrillation: better swift than sorry.
    Lancet. 2025 Jun 23:S0140-6736(25)00676-2. doi: 10.1016/S0140-6736(25)00676.
    PubMed    


  25. DEHBI HM, Fischer U, Asberg S, Milling TJ, et al
    Collaboration on the optimal timing of anticoagulation after ischaemic stroke and atrial fibrillation: a systematic review and prospective individual participant data meta-analysis of randomised controlled trials (CATALYST).
    Lancet. 2025 Jun 23:S0140-6736(25)00439-8. doi: 10.1016/S0140-6736(25)00439.
    PubMed     Abstract available


    May 2025
  26. ASHCRAFT S
    Safety of low-intensity monitoring after thrombolysis in acute ischaemic stroke.
    Lancet. 2025;405:1884-1885.
    PubMed    


  27. ANDERSON CS, Summers D, Ouyang M, Sui Y, et al
    Safety and efficacy of low-intensity versus standard monitoring following intravenous thrombolytic treatment in patients with acute ischaemic stroke (OPTIMISTmain): an international, pragmatic, stepped-wedge, cluster-randomised, controlled non-inferio
    Lancet. 2025 May 20:S0140-6736(25)00549-5. doi: 10.1016/S0140-6736(25)00549.
    PubMed     Abstract available


  28. SONG L, Li Q, Anderson CS
    Traditional Chinese medicine for acute intracerebral haemorrhage - Authors' reply.
    Lancet. 2025;405:1741-1742.
    PubMed    


  29. CHEN Y, Liang X, Liu Z
    Traditional Chinese medicine for acute intracerebral haemorrhage.
    Lancet. 2025;405:1741.
    PubMed    


  30. XU X, Fan H, Liu Q
    Traditional Chinese medicine for acute intracerebral haemorrhage.
    Lancet. 2025;405:1740.
    PubMed    


  31. ZHANG F, Wang Z, Kong W, Zhang W, et al
    Traditional Chinese medicine for acute intracerebral haemorrhage.
    Lancet. 2025;405:1739.
    PubMed    


  32. ZHU Y, Hu J, Ji S, Huang M, et al
    Traditional Chinese medicine for acute intracerebral haemorrhage.
    Lancet. 2025;405:1739-1740.
    PubMed    


  33. FAN AY, Gu S, Gong C
    Traditional Chinese medicine for acute intracerebral haemorrhage.
    Lancet. 2025;405:1738.
    PubMed    


  34. JIA H, Liu W, Fan X, Li Y, et al
    Traditional Chinese medicine for acute intracerebral haemorrhage.
    Lancet. 2025;405:1738-1739.
    PubMed    


  35. LUO R, Hui H, Ge H, Ran X, et al
    Traditional Chinese medicine for acute intracerebral haemorrhage.
    Lancet. 2025;405:1737-1738.
    PubMed    


    March 2025
  36. CHOI KH, Park YH, Lee JY, Jeong JO, et al
    Efficacy and safety of clopidogrel versus aspirin monotherapy in patients at high risk of subsequent cardiovascular event after percutaneous coronary intervention (SMART-CHOICE 3): a randomised, open-label, multicentre trial.
    Lancet. 2025 Mar 28:S0140-6736(25)00449-0. doi: 10.1016/S0140-6736(25)00449.
    PubMed     Abstract available


    February 2025
  37. VELTKAMP R, Korompoki E, Harvey KH, Harvey ER, et al
    Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): a multicentre, open-label, randomised, phase 3 trial.
    Lancet. 2025 Feb 26:S0140-6736(25)00333-2. doi: 10.1016/S0140-6736(25)00333.
    PubMed     Abstract available


  38. CHRISTENSON J, Hill MD, Swartz RH, Adams C, et al
    Efficacy and safety of intravenous nerinetide initiated by paramedics in the field for acute cerebral ischaemia within 3 h of symptom onset (FRONTIER): a phase 2, multicentre, randomised, double-blind, placebo-controlled study.
    Lancet. 2025;405:571-582.
    PubMed     Abstract available


  39. HILL MD, Goyal M, Demchuk AM, Menon BK, et al
    Efficacy and safety of nerinetide in acute ischaemic stroke in patients undergoing endovascular thrombectomy without previous thrombolysis (ESCAPE-NEXT): a multicentre, double-blind, randomised controlled trial.
    Lancet. 2025;405:560-570.
    PubMed     Abstract available


  40. KOOHI N, Simonyan S, Joffily L, Simister R, et al
    Testing hearing in suspected stroke: a diagnostic opportunity.
    Lancet. 2025;405:540-541.
    PubMed    


  41. LI W, Lan J, Wei M, Liu L, et al
    Normobaric hyperoxia combined with endovascular treatment for acute ischaemic stroke in China (OPENS-2 trial): a multicentre, randomised, single-blind, sham-controlled trial.
    Lancet. 2025;405:486-497.
    PubMed     Abstract available


  42. DIPPEL DWJ, Janssen PM
    Effect of normobaric hyperoxia in ischaemic stroke.
    Lancet. 2025;405:442-443.
    PubMed    


    January 2025
  43. FISCHER U, Butikofer L, Raabe A, Beck J, et al
    Decompressive craniectomy for people with intracerebral haemorrhage: the SWITCH trial - Authors' reply.
    Lancet. 2025;405:31-32.
    PubMed    


  44. MARSCHNER IC
    Decompressive craniectomy for people with intracerebral haemorrhage: the SWITCH trial.
    Lancet. 2025;405:31.
    PubMed    


  45. ENGRAND N, Miry L
    Decompressive craniectomy for people with intracerebral haemorrhage: the SWITCH trial.
    Lancet. 2025;405:30-31.
    PubMed    


  46. FRONTERA JA, Morris NA
    Decompressive craniectomy for people with intracerebral haemorrhage: the SWITCH trial.
    Lancet. 2025;405:30.
    PubMed    


  47. ROEPKE RML, Adler Maccagnan Pinheiro Besen B
    Decompressive craniectomy for people with intracerebral haemorrhage: the SWITCH trial.
    Lancet. 2025;405:29-30.
    PubMed    


    December 2024
  48. HO JK, Hankey GJ
    Endovascular therapy for ischaemic stroke due to vertebrobasilar artery occlusion.
    Lancet. 2024 Dec 11:S0140-6736(24)02137-8. doi: 10.1016/S0140-6736(24)02137.
    PubMed    


  49. NOGUEIRA RG, Jovin TG, Liu X, Hu W, et al
    Endovascular therapy for acute vertebrobasilar occlusion (VERITAS): a systematic review and individual patient data meta-analysis.
    Lancet. 2024 Dec 11:S0140-6736(24)01820-8. doi: 10.1016/S0140-6736(24)01820.
    PubMed     Abstract available


    November 2024
  50. DHILLON PS, Nguyen TN
    Temporary blood flow arrest during endovascular thrombectomy for acute ischaemic stroke.
    Lancet. 2024 Nov 20:S0140-6736(24)02461-9. doi: 10.1016/S0140-6736(24)02461.
    PubMed    


  51. LIU J, Zhou Y, Zhang L, Li Z, et al
    Balloon guide catheters for endovascular thrombectomy in patients with acute ischaemic stroke due to large-vessel occlusion in China (PROTECT-MT): a multicentre, open-label, blinded-endpoint, randomised controlled trial.
    Lancet. 2024 Nov 20:S0140-6736(24)02315-8. doi: 10.1016/S0140-6736(24)02315.
    PubMed     Abstract available


  52. WU S
    Integrative medicine for the treatment of stroke.
    Lancet. 2024 Nov 12:S0140-6736(24)02257-8. doi: 10.1016/S0140-6736(24)02257.
    PubMed    


  53. GUO J, Chen X, Wu M, Wang D, et al
    Traditional Chinese medicine FYTF-919 (Zhongfeng Xingnao oral prescription) for the treatment of acute intracerebral haemorrhage: a multicentre, randomised, placebo-controlled, double-blind, clinical trial.
    Lancet. 2024 Nov 12:S0140-6736(24)02261-X. doi: 10.1016/S0140-6736(24)02261.
    PubMed     Abstract available


  54. WOLF ME, Roser E, Bazner H
    Embolic stroke and patent foramen ovale in a 43-year-old fan chanting during a football match.
    Lancet. 2024;404:1760.
    PubMed    


  55. THOMALLA G, Bonekamp S, Fiehler J, Bendszus M, et al
    Endovascular thrombectomy for acute ischaemic stroke: the TENSION trial - Authors' reply.
    Lancet. 2024;404:1729-1730.
    PubMed    


  56. JHOU HJ, Yang LY, Chen PH
    Endovascular thrombectomy for acute ischaemic stroke: the TENSION trial.
    Lancet. 2024;404:1728.
    PubMed    


  57. WANG Z, Huang K, Huang ZX
    Endovascular thrombectomy for acute ischaemic stroke: the TENSION trial.
    Lancet. 2024;404:1728-1729.
    PubMed    


  58. BROOCKS G, Kemmling A
    Endovascular thrombectomy for acute ischaemic stroke: the TENSION trial.
    Lancet. 2024;404:1727-1728.
    PubMed    


    October 2024
  59. WERRING DJ, Dehbi HM, Ahmed N, Arram L, et al
    Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trial.
    Lancet. 2024 Oct 23:S0140-6736(24)02197-4. doi: 10.1016/S0140-6736(24)02197.
    PubMed     Abstract available


  60. SANDSET EC, de Sousa DA
    Optimal anticoagulation timing after ischaemic stroke in patients with atrial fibrillation.
    Lancet. 2024 Oct 23:S0140-6736(24)02259-1. doi: 10.1016/S0140-6736(24)02259.
    PubMed    


    September 2024
  61. NGUYEN TN, Abdalkader M, Fischer U, Qiu Z, et al
    Endovascular management of acute stroke.
    Lancet. 2024;404:1265-1278.
    PubMed     Abstract available


  62. PREVEL R, Boyer A, Gruson D, Orieux A, et al
    Catheter ablation for atrial fibrillation, atrio-oesophageal fistula, cerebral air embolism, and hyperbaric oxygen therapy.
    Lancet. 2024;404:1051-1052.
    PubMed    


    August 2024
  63. CASADO-NARANJO I, Portilla-Cuenca JC, Duarte-Martin JJ, Moyano-Calvente SL, et al
    Multiple intracerebral haemorrhages and ubiquitous brain microbleeds in a patient with Down syndrome: cerebral amyloid angiopathy.
    Lancet. 2024;404:e4.
    PubMed    


  64. JAVED S, Zaidi DA, Yaqoob E
    Addressing the deficiencies in stroke care in Pakistan.
    Lancet. 2024;404:651-652.
    PubMed    


    June 2024
  65. RAJ R, Tommiska P, Koivisto T, Leinonen V, et al
    Burr-hole drainage with or without irrigation for chronic subdural haematoma (FINISH): a Finnish, nationwide, parallel-group, multicentre, randomised, controlled, non-inferiority trial.
    Lancet. 2024;403:2798-2806.
    PubMed     Abstract available


  66. SHIBAHASHI K
    Optimising treatment for chronic subdural haematoma.
    Lancet. 2024;403:2757-2759.
    PubMed    


  67. LIU J, Li Y, Ge J, Yan X, et al
    Lowering systolic blood pressure to less than 120 mm Hg versus less than 140 mm Hg in patients with high cardiovascular risk with and without diabetes or previous stroke: an open-label, blinded-outcome, randomised trial.
    Lancet. 2024 Jun 27:S0140-6736(24)01028-6. doi: 10.1016/S0140-6736(24)01028.
    PubMed     Abstract available


  68. KELLY P, Lemmens R, Weimar C, Walsh C, et al
    Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trial.
    Lancet. 2024 Jun 7:S0140-6736(24)00968-1. doi: 10.1016/S0140-6736(24)00968.
    PubMed     Abstract available


  69. KATSANOS AH, Shoamanesh A
    Colchicine for the prevention of vascular events after non-cardioembolic stroke.
    Lancet. 2024 Jun 7:S0140-6736(24)01096-1. doi: 10.1016/S0140-6736(24)01096.
    PubMed    


    May 2024
  70. COUTTS SB, Ankolekar S, Appireddy R, Arenillas JF, et al
    Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial.
    Lancet. 2024 May 16:S0140-6736(24)00921-8. doi: 10.1016/S0140-6736(24)00921.
    PubMed     Abstract available


  71. SACCO S, Turc G
    Advances and challenges in the acute treatment of minor ischaemic stroke.
    Lancet. 2024 May 16:S0140-6736(24)00981-4. doi: 10.1016/S0140-6736(24)00981.
    PubMed    


  72. HILKENS NA, Casolla B, Leung TW, de Leeuw FE, et al
    Stroke.
    Lancet. 2024 May 14:S0140-6736(24)00642-1. doi: 10.1016/S0140-6736(24)00642.
    PubMed     Abstract available


  73. BECK J, Fung C, Strbian D, Butikofer L, et al
    Decompressive craniectomy plus best medical treatment versus best medical treatment alone for spontaneous severe deep supratentorial intracerebral haemorrhage: a randomised controlled clinical trial.
    Lancet. 2024 May 14:S0140-6736(24)00702-5. doi: 10.1016/S0140-6736(24)00702.
    PubMed     Abstract available


  74. KLIJN CJ, Dammers R, Sprigg N
    Decompressive craniectomy for deep intracerebral haemorrhage: a SWITCH towards better outcomes?
    Lancet. 2024 May 14:S0140-6736(24)00703-7. doi: 10.1016/S0140-6736(24)00703.
    PubMed    


    March 2024
  75. MELLO A, Stehr D, Bujarski K, Duchaine B, et al
    Visualising facial distortions in prosopometamorphopsia.
    Lancet. 2024;403:1176.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Cerebrovascular Disorders is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum